Literature DB >> 1744712

Application of (methyl-11C)-methionine in the multicellular spheroid system.

I Gáti1, M Bergström, C Muhr, B Långström, J Carlsson.   

Abstract

Human glioma (U-343 MGa) and human colon carcinoma (HT-29) cell lines were cultured as multicellular spheroids, and the accumulations of the L- and D-enantiomers of 11C-methionine were investigated. The accumulation of radioactivity in the spheroids was expressed as relative counts, by dividing the radioactivity measured in the spheroid with the radioactivity of the same volume of the incubation medium. The experiments were verified using 14C-labeled L- and D-methionine. The influence of spheroid volume, specific activity, incubation time, washing time, and the environmental temperatures were investigated. The spheroid model was used to determine the effect of the lipoxygenase inhibitors BW A4C and AA-861, the ether-phospholipid type PAF-antagonist CV-6209 and the protein synthesis inhibitor cycloheximide on methionine uptake. The results showed that 11C-L-methionine can be applied in the study of drug effects on multicellular tumor cell aggregates.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744712

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Effect of α, β momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines.

Authors:  Gunasekar Manoharan; Seema R Jaiswal; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2013-12-03       Impact factor: 3.396

2.  A new, fast and semi-automated size determination method (SASDM) for studying multicellular tumor spheroids.

Authors:  Azita Monazzam; Pasha Razifar; Orjan Lindhe; Raymond Josephsson; Bengt Långström; Mats Bergström
Journal:  Cancer Cell Int       Date:  2005-11-14       Impact factor: 5.722

3.  Multicellular tumour spheroid as a model for evaluation of [18F]FDG as biomarker for breast cancer treatment monitoring.

Authors:  Azita Monazzam; Pasha Razifar; Martin Simonsson; Fredrik Qvarnström; Raymond Josephsson; Carl Blomqvist; Bengt Långström; Mats Bergström
Journal:  Cancer Cell Int       Date:  2006-03-23       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.